📢 Excited to share our recent study on oral vancomycin therapy (OVT) in IBD-PSC!
In our systematic review of 290 pts, OVT was associated with:
✅ Clinical response in 47.6%
✅ Biochemical remission in 68.8%
🔗 Read the full study: https://t.co/EEdaeoPlmc
(1/2)
pheochromocytoma is ridiculed as a zebra dx with an incidence of 0.8/100,000 pt years
withholding ondansetron d/t risk of TdP is considered reasonable care when the incidence of drug-induced TdP is 0.4/100,000 pt years
1/Do radiologists sound like they are speaking a different language when they talk about MRI?
T1 shortening what? T2 prolongation who?
Here’s a translation w/an introductory thread to MRI.
It was an unbelievable experience to present our research at #SCAI2024@SCAI All sessions were thought-provoking and informative, and I am definitely feeling inspired as I leave Long Beach! Can’t wait for DC in 2025 👊🔥
ICU Pharmacology Secrets:
Some drug side effects, even if relatively rare, are well entrenched in our memory. For example, most intensivists & hospitalists are aware of cefepime-induced neurotoxicity or clindamycin’s association w C difficile infection (or even the seemingly
Excited to present our work @DDWMeeting ! Looking forward to meeting friends, colleagues, and mentors! I thank Dr. @Badr_AlBawardy for his support and mentorship! #DDW2024#GITwitter
The #TopGUTAuthor2023 chosen by @emadelomar is Professor Michael Camilleri
Read the #RecentAdvancesInClinicalPractice paper by Prof Camilleri "Abnormal gastrointestinal motility is a major factor in explaining symptoms and a potential therapeutic..." via https://t.co/Cw1Ac0ZeHS